Investigating the Effect of Transdiagnostic Group Intervention on Depression, Anxiety, and Postpartum Stress in Women With Preeclampsia: A Quasi‐Experimental Study Authors: Zahra Hatami Asl, Nasrin Jaberghaderi, Mansor Rezaei, Negin Rezavand, Mastaneh Kamravamanesh Published: 2026 ABSTRACT ABSTRACTBackground and ObjectiveWomen with preeclampsia are at increased risk of postpartum mood and psychological disorders. This study examined the effect of a group‐based transdiagnostic intervention on depression, anxiety, and stress in this population.MethodsIn this semi‐experimental, single‐blind study using a pretest–posttest control design, 95 postpartum women with a history of preeclampsia were recruited from Imam Reza (AS) Hospital in Kermanshah. Participants were randomly assigned via block randomization to either the intervention group (n = 48) or the control group (n = 47). The intervention comprised eight 45–60‐min group sessions delivered using a transdiagnostic protocol, whereas the control group received routine postpartum care. Outcomes were assessed using the Edinburgh Postnatal Depression Scale and the DASS‐21 at baseline, 1 week, and 2 months after the intervention. Data were analyzed using SPSS version 25.ResultsThe intervention group showed a significant decrease in depression (1.54 ± 0.43), anxiety (2.13 ± 0.40), and stress (1.5 ± 0.54) in both follow‐up periods compared to baseline (p < 0.05), while no change was observed in the control group.ConclusionGroup‐based transdiagnostic training effectively improves postpartum depression, anxiety, and stress in women with preeclampsia and may be integrated into postpartum care protocols for high‐risk pregnancies.Keywords: anxiety, cognitive‐behavioral therapy, depression, perinatal mental health, postpartum, preeclampsia, stress, transdiagnostic Introduction Preeclampsia, whether occurring on its own or superimposed on chronic hypertension, is among the most severe hypertensive disorders of pregnancy and a pregnancy‐specific syndrome that may impact nearly every organ system in the body [1]. Preeclampsia is usually characterized by elevated blood pressure and proteinuria [2]. Preeclampsia represents a severe hypertensive syndrome specific to gestation, with the potential to cause multi‐organ damage. It is recognized as a primary contributor to worldwide maternal and perinatal mortality. Recent data suggest a global prevalence of approximately 4.4% (within a 2%–8% range), though substantial regional variation exists. The higher impact observed in LMICs is largely linked to inadequate prenatal services and systematic healthcare challenges [3]. Although the physical symptoms of preeclampsia usually resolve after childbirth, women who experience this condition are at increased risk for postpartum mental health disorders compared with women who have normotensive pregnancies [4]. Research has demonstrated significant associations between maternal psychological conditions—such as anxiety and depression—and preeclampsia [5]. In addition, PTSD occurs at a notably high rate following preeclampsia, with cesarean delivery, limited social support, and postpartum depression identified as major risk factors [6]. Another common psychiatric condition among women with preeclampsia is postpartum depression (PPD) [5]. Postpartum depression is a mood disorder that typically emerges between 2 weeks and 1 year after delivery [7]. Its global prevalence ranges from 3% to 38%, and studies indicate that gestational hypertension is a significant risk factor, with depression rates reported between 20% and 30% in this population [8]. When left untreated, postpartum depression can continue for months or years, resulting in weakened mother–infant bonding, strained family relationships, reduced maternal functioning, and, in severe cases, maternal suicide or infanticide [7]. Even with these risks, postpartum care for women who have had preeclampsia typically prioritizes physical healing over mental health screening and intervention. Implementing targeted mental health screenings for this high‐risk population could help ensure early detection, appropriate referrals, and prompt treatment for psychological conditions [9]. In addition to pharmacological treatment, psychological interventions—especially cognitive‐behavioral therapy (CBT)—have received increasing attention in the management of postpartum mental health disorders. CBT combines cognitive and behavioral methods, including behavior modification, cognitive restructuring, problem‐solving, relaxation, and interpersonal skills training, to target maladaptive thoughts, emotions, and behaviors [10]. Numerous studies have demonstrated the effectiveness of CBT in reducing symptoms of anxiety, stress, and depression [11]. One innovative approach within the CBT framework is integrative transdiagnostic therapy [12]. This treatment model aims to equip individuals with skills to effectively regulate negative emotions across a range of psychological disorders [13]. The protocol is designed to address five key areas: developing awareness of emotions in the moment, enhancing cognitive flexibility, decreasing behaviors that involve avoiding emotions, increasing tolerance for physical sensations, and engaging in exposure to situations that trigger emotions [14]. Grounded in the three‐component model of emotion (thoughts, feelings, and behaviors), transdiagnostic therapy emphasizes present‐moment awareness and adaptive emotional regulation, allowing individuals to recognize and modify ineffective coping strategies [15]. Research indicates that transdiagnostic interventions are effective for perinatal populations. For instance, a clinical trial in Iran during 1400 showed that integrating online transdiagnostic therapy led to significant reductions in emotional distress and increased psychological empowerment among pregnant women [16]. Similarly, a quasi‐experimental study in Egypt (2020) found that CBT effectively reduced anxiety, stress, and pregnancy‐specific depression in women with preeclampsia while improving coping strategies in high‐risk pregnancies [17]. Notwithstanding this increasing body of evidence, research specifically investigating the effectiveness of transdiagnostic therapy for postpartum mental health disorders in women with preeclampsia has not yet been conducted. This highlights a critical need for psychological support during the postpartum period [18]. Midwives, as key members of the maternal healthcare team, play a vital role in identifying postpartum depression, providing counseling, and facilitating referrals for psychological treatment when necessary [19]. Accordingly, the present study aimed to determine the effect of a group‐based transdiagnostic intervention on depression, anxiety, and postpartum stress among women with preeclampsia referred to Imam Reza Hospital in Kermanshah. Materials and Methods This study employed a quasi‐experimental design with a pretest–posttest control group. The statistical population consisted of women with a history of preeclampsia in Kermanshah who had given birth between 2 months and 1 year prior to the study. Participants were selected using convenience sampling. The inclusion criteria were: age between 15 and 49 years; absence of severe mental disorders; no use of mood‐altering medications (including antidepressants); a score of 12 or higher on the Edinburgh Postnatal Depression Scale (EPDS); absence of suicidal ideation or intent to self‐harm; fulfillment of at least three DSM‐5 diagnostic criteria for major depressive disorder; delivery resulting in a healthy live infant; and a confirmed diagnosis of preeclampsia of varying severity during pregnancy or delivery based on clinical and paraclinical evidence and confirmed by a gynecologist. Cases with eclampsia were excluded. Preeclampsia severity was classified according to established clinical guidelines as follows: 1.Mild preeclampsia: Elevated blood pressure (systolic 140–159 mmHg and/or diastolic 90–109 mmHg) occurring after 20 weeks of gestation in women with previously normal blood pressure, accompanied by proteinuria ≥ 300 mg in a 24‐h urine sample, and without evidence of vital organ involvement. Mild preeclampsia: Elevated blood pressure (systolic 140–159 mmHg and/or diastolic 90–109 mmHg) occurring after 20 weeks of gestation in women with previously normal blood pressure, accompanied by proteinuria ≥ 300 mg in a 24‐h urine sample, and without evidence of vital organ involvement. 2.Severe preeclampsia: Presence of at least one of the following: systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 110 mmHg, severe proteinuria (≥ 5 g in a 24‐h urine sample), or signs and symptoms indicative of involvement of other organ systems. Severe preeclampsia: Presence of at least one of the following: systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 110 mmHg, severe proteinuria (≥ 5 g in a 24‐h urine sample), or signs and symptoms indicative of involvement of other organ systems. The exclusion criteria included severe complications of preeclampsia such as nephropathy, current use of psychiatric medications, absence from more than two intervention sessions, incomplete questionnaire responses, unwillingness to continue participation, and cases requiring referral to a psychiatrist. Following approval of the research protocol by Kermanshah University of Medical Sciences and ethical clearance from the Ethics Committee (IR.KUMS.REC.1402.386), eligible women with a documented history of preeclampsia were identified through medical records. After receiving a full explanation of the study objectives, participants completed a demographic information form, the EPDS, and the Depression, Anxiety, and Stress Scale (DASS‐21). Initial screening data were collected from medical records, and eligible individuals were contacted using the addresses listed in their files. After obtaining verbal agreement, a meeting time was scheduled, during which participants completed the EPDS. Women who scored ≥ 12 on the EPDS and reported no suicidal ideation subsequently underwent a semi‐structured telephone interview based on DSM‐5 criteria for major depressive disorder, conducted in collaboration with a trained clinical psychologist. Inter‐rater reliability for DSM‐5 diagnoses was evaluated using Cohen's kappa coefficient, which indicated good agreement between raters (κ = 0.80). After confirmation of eligibility, participants were randomly assigned to either the intervention or control group using block randomization with blocks of four (e.g., AABB, ABAB, BAAB) to ensure equal group sizes. Randomization was carried out by an independent research team member using random number generation software, with no involvement in assessment or intervention procedures. During the first session, the researcher explained the objectives of the study and obtained written informed consent from all participants. Baseline demographic and obstetric data, along with the DASS‐21, were completed by both groups. Due to the face‐to‐face nature of the educational intervention, blinding of participants and facilitators was not feasible; therefore, the study was conducted as a single‐blind (outcome‐assessor) trial. The intervention group participated in 8 weekly in‐person transdiagnostic group intervention sessions, each lasting 45–60 min, conducted by a researcher trained in cognitive behavioral therapy (CBT) and the integrated transdiagnostic treatment protocol for emotional disorders, under the supervision of a licensed psychological counselor. The intervention group was divided into four subgroups, each consisting of 12 participants. The control group received routine postpartum care per Iranian guidelines and did not receive any psychological intervention. Assessments were conducted at three time points: baseline (pre‐intervention), 1 week post‐intervention, and 2 months post‐intervention. Depression, anxiety, and stress scores were compared between the two groups across these time points. Baseline assessments were administered by the researcher, while follow‐up assessments at 1 week and 2 months post‐intervention were conducted by a trained health worker. The intervention content was derived from the 15‐session Unified Protocol for Transdiagnostic Treatment of Emotional Disorders developed by Barlow and colleagues. Based on the Persian translation by Dr. Ali Mehrabi and Dr. Abolfazl Mohammadi, and following expert review by faculty members of the Departments of Psychology and Psychiatry at Kermanshah University of Medical Sciences, an 8‐session version of the protocol was approved and implemented (Table 1). Table 1Summary of sessions of the integrated protocol for the transdiagnostic treatment of emotional disorders.SessionGoalMeeting contentEducational methodsTimeFirst sessionIncreasing motivation with motivational interviewing to engage patients during treatment and provide treatment rationaleEstablishing therapeutic communication, motivational interviewing to increase the motivation of postpartum women with preeclampsia to participate in the treatment process; providing therapeutic rationale and determining treatment goalsIn‐person, including questions and answers, presenting the protocol, using a video projector and whiteboard if possible, and giving and reviewing assignments.45–60 minSecond sessionProviding psychological training on recognizing emotions and tracking emotional experiencesProviding psychological training, recognizing and tracking emotions, and teaching the ABC model; learning to observe emotional experiences; receiving feedback, and providing homework.In‐person, including questions and answers, presenting the protocol, using a video projector and whiteboard if possible, and giving and reviewing assignments.45–60 minThird and fourth sessionEmotional awareness training: learning to observe emotional experiences (emotions and reactions to emotions)Reviewing homework; creating awareness to identify thought patterns and their effects on the pregnancy process; expressing the interrelationship between thoughts and emotions; cognitive reappraisal; receiving feedback and presenting homework.In‐person, including questions and answers, presenting the protocol, using a video projector and whiteboard if possible, and giving and reviewing assignments.45–60 minFifth sessionCognitive appraisal, reappraisal, and emotion avoidanceReview homework; identify behaviors influenced by emotion; be aware of types of emotional avoidance (behavioral, cognitive, safety cues); receive feedback and present homework.In‐person, including questions and answers, presenting the protocol, using a video projector and whiteboard if possible, and giving and reviewing assignments.45–60 minSixth sessionBehaviors caused by excitementReview homework; be aware of internal and external triggers of emotion; present the logic of emotional encounters; receive feedback and present homework.In‐person, including questions and answers, presenting the protocol, using a video projector and whiteboard if possible, and giving and reviewing assignments.45–60 minSeventh sessionAwareness and tolerance of physical sensationsReview homework; design imaginative and real emotional coping exercises and avoid avoidance; receive feedback and submit homework.In‐person, including questions and answers, presenting the protocol, using a video projector and whiteboard if possible, and giving and reviewing assignments.45–60 minEighth sessionRelapse preventionDiscussion of treatment advances and subjects' experiences; relapse prevention with a focus on prevention of emotional avoidance and emotional tolerance.In‐person, including questions and answers, presenting the protocol, using a video projector and whiteboard if possible, and giving and reviewing assignments.45–60 min Summary of sessions of the integrated protocol for the transdiagnostic treatment of emotional disorders. To ensure treatment fidelity, the intervention followed a standardized manual based on the adapted Unified Protocol. Session content was monitored using structured checklists, and the facilitator received ongoing supervision from a licensed psychological counselor to ensure adherence to the protocol. This study was reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT) guidelines to ensure transparency, reproducibility, and suitability for inclusion in systematic reviews. Sample Size and How to Determine It According to the studies by Hassan et al. [17] and Asghari et al. [20], and considering the depression, anxiety, and stress scores in these two studies after the intervention, calculations were made in the two intervention and control groups. According to the mean and standard deviation of the three variables above in the two groups and in both studies (6 cases), the sample size calculation formula was used to compare the means of the two quantitative variables. With a confidence level of 95% and a test power of 90%, at least 24, 16, 31, 12, and 47 people were considered in each group. Finally, with a confidence of 95% and a test power of 90%, the largest number of samples among the above 6 cases was at least 47 people in each group and 94 people in total. Data Collection Tool. 1.Demographic characteristics collection form: In this study, the demographic and obstetric characteristics of the study samples were collected, which included questions regarding education, occupation, spouse's education and occupation, telephone number, address, and questions about the severity of preeclampsia, type of delivery, gestational age at delivery, etc. Demographic characteristics collection form: In this study, the demographic and obstetric characteristics of the study samples were collected, which included questions regarding education, occupation, spouse's education and occupation, telephone number, address, and questions about the severity of preeclampsia, type of delivery, gestational age at delivery, etc. 2.Edinburgh Postpartum Depression Scale (EPDS): The Edinburgh Postpartum Depression Scale (EPDS) was designed and developed to measure postpartum depression in the past 7 days. This questionnaire was validated in Iran by Ahmadi Kani Golzar and Gholizadeh (2015) [21]. This questionnaire has 10 questions and is based on a Likert scale with questions such as (When things did not go my way, I blamed myself for no reason).The Edinburgh scale scores range from 0 to 30. Questions 1, 2, and 4 are scored from zero to three, and questions 3, 5, 6, 7, 8, 9, and 10 are scored from three to zero. To calculate the overall score for the questionnaire, add up the scores for all items on the questionnaire. The range of scores for this questionnaire is from 0 to 30. The higher the score obtained from this questionnaire, the greater the level of postpartum depression. Edinburgh Postpartum Depression Scale (EPDS): The Edinburgh Postpartum Depression Scale (EPDS) was designed and developed to measure postpartum depression in the past 7 days. This questionnaire was validated in Iran by Ahmadi Kani Golzar and Gholizadeh (2015) [21]. This questionnaire has 10 questions and is based on a Likert scale with questions such as (When things did not go my way, I blamed myself for no reason). The Edinburgh scale scores range from 0 to 30. Questions 1, 2, and 4 are scored from zero to three, and questions 3, 5, 6, 7, 8, 9, and 10 are scored from three to zero. To calculate the overall score for the questionnaire, add up the scores for all items on the questionnaire. The range of scores for this questionnaire is from 0 to 30. The higher the score obtained from this questionnaire, the greater the level of postpartum depression. 3.Depression, Anxiety, and Stress Scale 21 (DASS21): Validity and reliability of the Depression, Anxiety, and Stress Scale (DASS) were examined. Antony et al. subjected the scale to factor analysis, and their results again indicated the existence of three factors: depression, anxiety, and stress. The results of this study showed that 68% of the total variance of the scale was measured by these three factors. The eigenvalues of the stress, depression, and anxiety factors in the study were 9.07, 2.89, and 1.23, respectively, and the alpha coefficients for these three factors were 0.97, 0.92, and 0.95, respectively [22]. Also, in the study by Nik Azin and Naininian, Cronbach's alpha coefficients for the dimensions of depression, anxiety, and stress were 70%, 84%, and 82%, respectively, and the test‐retest coefficients for the aforementioned dimensions were 79%, 67%, and 64%, respectively, which are acceptable [23]. Depression, Anxiety, and Stress Scale 21 (DASS21): Validity and reliability of the Depression, Anxiety, and Stress Scale (DASS) were examined. Antony et al. subjected the scale to factor analysis, and their results again indicated the existence of three factors: depression, anxiety, and stress. The results of this study showed that 68% of the total variance of the scale was measured by these three factors. The eigenvalues of the stress, depression, and anxiety factors in the study were 9.07, 2.89, and 1.23, respectively, and the alpha coefficients for these three factors were 0.97, 0.92, and 0.95, respectively [22]. Also, in the study by Nik Azin and Naininian, Cronbach's alpha coefficients for the dimensions of depression, anxiety, and stress were 70%, 84%, and 82%, respectively, and the test‐retest coefficients for the aforementioned dimensions were 79%, 67%, and 64%, respectively, which are acceptable [23]. The Depression, Anxiety, and Stress Questionnaire consists of 21 items, which are related to symptoms of negative emotions (depression, anxiety, and stress). The depression subscale includes items that measure unhappy mood, lack of self‐confidence, hopelessness, worthlessness of life, lack of interest in engaging in activities, lack of enjoyment of life, and lack of energy and strength. The anxiety subscale includes items that attempt to assess physiological arousal, fears, and situational anxiety, and the stress subscale includes items such as difficulty in achieving calm, nervous tension, irritability, and restlessness. The EPDS and DASS‐21 have been validated in Iranian populations. In the present study, internal consistency was high, with Cronbach's α values of, for example, 0.92 for the DASS‐21 depression subscale. The questionnaire components are shown in Table 2. Table 2Components of the depression, anxiety, and stress questionnaire.SubscalesQuestionsDepression3‐5‐10‐13‐16‐17‐21Anxiety2‐4‐7‐9‐15‐19‐20Stress1‐6‐8‐11‐12‐14‐18 Components of the depression, anxiety, and stress questionnaire. Each subscale of the DASS‐21 consists of seven questions, the final score of which is obtained by summing the scores of the related questions (Table 2). Each question is scored from zero (does not apply to me at all) to three (completely applies to me). Since this questionnaire is a shortened form of the original scale (42 questions), the final score of each subscale should be doubled. Then, by referring to Table 3, the severity of symptoms can be determined. The scoring of the questionnaire is shown in Table 3. Table 3Severity of each of the depression, anxiety, and stress subscales.SeverityDepressionAnxietyStressNormal0–90–70–14Mild10–138–915–18Moderate14–2010–1419–25Severe21–2715–1926–33Very severe+28+20+33 Severity of each of the depression, anxiety, and stress subscales. Data Analysis Methods In the descriptive statistics section, the mean and standard deviation were used to describe and report quantitative variables with a normal distribution. The χ 2 test, Mann–Whitney test, and independent t‐test were used to examine the similarity of demographic variables between the experimental and control groups. The independent t‐test was used to examine the changes in the mean of the aforementioned scale in different time intervals, and the analysis of variance was used between three times in each group. The paired t‐test was used to compare both times in each group, and the Bonferroni post hoc test was used to compare both times in the analysis of variance with repeated values. Ratios and percentages were also expressed for qualitative variables. Paired t‐test or Wilcoxon was used for comparison before and after. The appropriate test for repeated data was also used. SPSS statistical software version 25 was used to analyze the data. The statistical significance level was considered to be 0.05. Findings A total of 95 postpartum women participated in the study, of whom 47 (49.5%) were allocated to the control group and 48 (50.5%) to the intervention group. Most participants had secondary or higher education, and the majority were homemakers. In terms of economic status, the largest proportion reported a monthly income exceeding 15 million tomans. The mean age of participants was 32.47 ± 6.63 years (range: 16–48 years), and the mean gestational age was 35.16 ± 3.09 weeks (range: 26–40 weeks). More than two‐thirds of the participants were experiencing their first or second pregnancy. The majority had preterm deliveries and underwent cesarean section. Regarding the severity of preeclampsia, participants were almost equally distributed between mild and severe categories. No statistically significant differences were observed between the intervention and control groups with respect to mode of delivery or severity of preeclampsia (p > 0.05). To compare the two groups at each time point, the t‐test was used, and to compare the means of each group at three times, the repeated measures design test was used. Table 4 shows the descriptive results of the pre‐test, 1 week after the intervention, and 2 months after the intervention of the mean postpartum depression, anxiety, and stress scales of women with preeclampsia in the intervention and control groups. Accordingly, in the intervention group, the mean postpartum depression, anxiety, and stress scores of women with preeclampsia decreased significantly in 1 week and 2 months after the intervention, respectively, compared to the pre‐test, which was not observed in the control group. Also, based on the results, the mean depression, anxiety, and stress scores of pregnant women were lower than the pre‐test in 1 week and 2 months after the intervention. Analysis of the findings from the independent t‐test to compare the mean scores of depression, anxiety, and postpartum stress in women with preeclampsia showed that there was a significant difference between the mean scores of depression, anxiety, and postpartum stress in women with preeclampsia 2 months after the intervention in the study groups (p < 0.05) (Table 4). Table 4Comparison of mean scores on the depression, anxiety, and stress scales at pretest, posttest, and follow‐up in the intervention and control groups.**Statistical indicatorControlInterventionVariable/timeMean ± standard deviationMean ± standard deviation p = 0/925 t = −/094 11/2 ± 33/28711/2 ± 88/376One week before interventionDepression p = 0/116 t = 1/584 11/2 ± 47/27310/2 ± 69/519One week after intervention p = < 0/001 t = 0/673 10/2 ± 74/1416/1 ± 85/978Two months after intervention p = < 0/001 F = 28/713 p = < 0/001 F = 195/411 *Statistical indicator p = 0/394 t = 0/856 12/2 ± 74/29812/2 ± 35/49One week before interventionAnxiety p = 0/013 t = 2/526 12/2 ± 19/00711/2 ± 08/258One week after intervention p = < 0/001 t = 11/418 11/1 ± 83/9486/2 ± 94/216Two months after intervention p = < 0/001 F = 32/737 p = < 0/001 F = 188/848 *Statistical indicator p = 0/950 t = 0/063 11/2 ± 85/82111/3 ± 81/126One week before interventionStress p = 0/220 t = 1/234 11/2 ± 49/81210/2 ± 77/860One week after intervention p = < 0/001 t = −7/457 11/2 ± 17/7927/2 ± 19/403Two months after intervention p = < 0/001 F = 18/520 p = < 0/001 F = 75/340 *Statistical indicator Comparison of mean scores on the depression, anxiety, and stress scales at pretest, posttest, and follow‐up in the intervention and control groups. p = 0/925 t = −/094 p = 0/116 t = 1/584 p = < 0/001 t = 0/673 p = < 0/001 F = 28/713 p = < 0/001 F = 195/411 p = 0/394 t = 0/856 p = 0/013 t = 2/526 p = < 0/001 t = 11/418 p = < 0/001 F = 32/737 p = < 0/001 F = 188/848 p = 0/950 t = 0/063 p = 0/220 t = 1/234 p = < 0/001 t = −7/457 p = < 0/001 F = 18/520 p = < 0/001 F = 75/340 The test results show that there is a significant difference between the mean scores of depression, anxiety, and stress 1 week before the intervention and 1 week after the intervention (p< 0.05), 1 week before the intervention and 2 months after the intervention (p < 0.05), and 1 week after the intervention and 2 months after the intervention (p < 0.05) (Table 5). Table 5Within‐group comparison with the Bonferroni test on depression, anxiety, and stress scales.95% confidence intervalUpper limitLower limit p valueStandard errorAverage differenceTimeVariable973/0576/0001/0>1/00.775One week before interventionDepression39/371/2001/0>172/03.053One week after intervention62/294/1001/0>173/02.258Two months after intervention127/1697/0001/0>108/00.912One week before interventionAnxiety537/379/2001/0>187/0166/3One week after intervention58/292/1001/0>167/0254/2Two months after intervention903/0500/0001/0>101/0702/0One week before interventionStress067/323/2001/0>208/0653/2One week after intervention29/2612/1001/0>171/0951/1Two months after intervention Within‐group comparison with the Bonferroni test on depression, anxiety, and stress scales. The findings of the Bonferroni test for pairwise comparison of groups showed that there was a significant difference between the mean scores of depression, anxiety, and stress in the intervention group and the control group (p < 0.05) (Table 6). Table 6Between‐group comparison with Bonferroni test on depression, anxiety, and stress scales.95% confidence interval p valueStandard errorAverage differenceGroupsVariableUpper limitLower limit398/2686/0001/0431/0542/1Intervention and controlDepression929/2332/1001/0402/0130/2Intervention and controlAnxiety660/2005/0005/0544/0580/1Intervention and controlStress Between‐group comparison with Bonferroni test on depression, anxiety, and stress scales. The chart above shows the rate of postpartum depression in women with a history of preeclampsia in the control and intervention groups separately and at the times before the intervention, 1 week after, and 2 months after the intervention. According to this chart, the trend of depression in the intervention group is decreasing (Figure 1). Trend of changes in the mean depression score of the two groups at three times. According to the results, the effect of the intervention on the anxiety questionnaire score of women with a history of preeclampsia is highly significant, and according to the chart, the average anxiety score of the intervention group is much lower than that of the control group (Figure 2). Trend of changes in the average anxiety score of the two groups at three times. According to the results, the effect of the intervention on the stress questionnaire score of women with a history of preeclampsia is highly significant, and according to the chart, the average stress score of the intervention group is much lower than that of the control group (Figure 3). Trend of changes in the average stress score of the two groups at three times. Discussion The results obtained in this study showed that before the intervention, there was no statistically significant difference between the mean depression score in the experimental and control groups, while 1 week after the intervention and at the follow‐up time 2 months after the intervention, a statistically significant difference was observed between the mean depression score in the aforementioned groups. Goudarzi et al. concluded in a clinical trial with a pre‐test, post‐test, and follow‐up design that the transdiagnostic intervention created a significant difference in the mean depression score in the intervention and control groups, and these two groups had a significant difference [16]. This was consistent with the results of the present study. The results of repeated measures analysis in the present study showed that the intervention on postpartum depression in women with preeclampsia caused a significant decrease in the level of depression in these women over time, and there was a significant difference between the two groups, which was consistent with the results of the study by Hassan et al. and Ye et al. [8, 17]. The results of the study by Hassan et al. (2020) entitled “The Effect of Cognitive‐Behavioral Therapy on Anxiety, Stress, Depression, and Coping Pattern in Pregnant Women with Preeclampsia” showed that after the intervention (12 sessions of CBT), there was a statistically significant difference in depression, anxiety, and stress scores compared to before cognitive‐behavioral therapy in the intervention group [17]. Also, Carta et al. agreed with this issue and reported that mothers had a significant improvement in postpartum depression after receiving CBT [24]. In other interventions where people received mindfulness‐based treatments, they had greater reductions in symptoms of depression and stress than the control group, suggesting that mindfulness‐based interventions can improve depressive symptoms [25]. Studies have shown that transdiagnostic interventions can also be effective in treating postpartum depression in women with preeclampsia. The results of the present study showed that after the intervention, there was a statistically significant difference between the mean anxiety scores in the experimental and control groups. The results of the present study were consistent with the results of studies by Ellard et al. [26] and Farchione et al. [27] which examined the effectiveness of transdiagnostic treatment in depressed and anxious samples, and provided further empirical support for the effectiveness of the transdiagnostic treatment approach [26, 27]. The results of the present study showed that the intervention significantly reduced postpartum anxiety in women with preeclampsia over time. This study is consistent with the studies of Zemestani and Imani, Kamali et al. and Li et al. [28, 29, 30]. In the Zemestani and Imani study, the findings of the study showed that transdiagnostic treatment is effective in reducing symptoms of depression, anxiety, and also in modifying emotion regulation strategies [29]. In explaining this hypothesis, it can be stated that one of the fundamental skills in the transdiagnostic protocol is the skill of emotional awareness, which emphasizes non‐judgmental and present‐focused awareness of emotional experience. This skill is achieved by understanding the adaptive nature of emotions and increasing emotional awareness using mindfulness techniques. The result of transdiagnostic therapy is that patients have a better understanding of the interaction of the three components (thoughts, feelings, and behavior) in creating internal emotional experiences. The results of this study showed that after the intervention, there was a statistically significant difference between the mean stress scores in the experimental and control groups. These results are consistent with the study by Ito et al.(2016), who showed in their study that integrated transdiagnostic therapy reduced anxiety among women [31]. The results of the study by Holakouee et al.(2022) also showed that integrative transdiagnostic therapy is not only effective in reducing stress and anxiety, but also effective in reducing depression and increasing positive interactions between adolescents and their parents [32]. In explaining the above results, it can be said that one of the techniques of integrative transdiagnostic treatment is confronting the individual with anxiety and stress‐inducing symptoms. In this way, the individual is confronted hierarchically with anxiety‐inducing events and physical and psychological factors that cause anxiety and stress, and this confrontation continues to the extent that the individual's sensitivity to the stressful event and the individual's misinterpretation of anxiety symptoms that are experienced physically and psychologically are reduced. In fact, integrative transdiagnostic treatment leads to a reduction in symptoms by using acceptance of emotions, giving validity to the patient's emotions, as well as changing false metacognitive beliefs and teaching patients not to judge emotions and simply observe them [33]. The results showed that transdiagnostic therapy improved stress symptoms in the intervention group for women with a history of preeclampsia. This result is also consistent with the findings of Green et al., Netsi et al. [34, 35]. However, we believe that cognitive behavioral therapy has significant effects on reducing stress symptoms, which may be related to the type of method used. Therefore, the most influential factor in causing anxiety and stress may be related to dysfunctional thoughts and false beliefs about pregnancy and childbirth. As with many applications of meditation techniques related to CBT, there is value in framing CBT in the context of relaxation or stress management. This is notable in relation to preeclampsia, as stress is a common trigger of complications in pregnancy [36]. CBT provides individuals with a high level of ability to simply observe feelings, behaviors, and experiences, eliminate automatic and often dysfunctional reactions, and allow themselves to function and develop more rational and balanced relationships. In women with preeclampsia, psychotherapy may regulate emotions and feelings and psychosocial modifications. Thus, problematic health behavior is reduced. The collaboration of midwives, obstetricians, and psychiatrists as a team in the treatment of psychological disorders (anxiety, depression, and pregnancy‐specific stress) can help improve women's adverse conditions during pregnancy and postpartum. In addition, the effectiveness of other psychological treatments in the treatment of mental disorders in women with preeclampsia is essential. The results of a study conducted by Asghari et al. are closely related to the results of the present study, which showed that the mean total score of the Pregnancy Stress and Worries Questionnaire was 21.12 ± 15.06 in the intervention group and 39.09 ± 19.55 in the control group [20]. Similarly, Jabari et al. reported a significant improvement in stress and anxiety levels in the intervention group compared to the control group [37]. Furthermore, CBT reduces stress and psychological symptoms, which is consistent with the results of Stewart, who explained that stress can stimulate the sympathetic nervous system and adrenal glands. Subsequently, it can increase heart rate, respiratory rate, and cause high blood pressure [37]. Significant reductions in anxiety and depression levels have been reported after CBT [34]. While Netsi et al. showed that women with depression had better night's sleep after CBT than the control group [35]. Also, Mahmoudjanlou et al.(2016) stated that CBT reduces stress levels in pregnant women and that CBT is safer than medication for anxiety disorders during pregnancy [38]. In a transdiagnostic intervention with factors that lead to depression, anxiety, stress, and lack of emotional control in women with a history of pregnancy complications such as preeclampsia, it teaches how to reduce these emotions. Also, by training mindfulness in people with depression, anxiety, and stress, it is possible to teach ways to deal with those emotions by examining pleasant daily activities versus unpleasant activities and planning for pleasant activities. In fact, in the mindfulness sessions held in this study, women who have given birth with a history of preeclampsia were able to discuss effective coping strategies with depression, anxiety, and stress, and learn more practical ways. In fact, all of this causes women who have given birth and have a history of preeclampsia to be in better psychological and emotional conditions, and due to their goal‐setting skills, understanding emotions and mindfulness, cognitive flexibility, and greater levels of emotional well‐being, they have a greater ability to use emotionally adaptive strategies. Conclusion This study demonstrated that group‐based transdiagnostic interventions can improve postpartum depression, anxiety, and stress in women with preeclampsia. The findings underscore the importance of integrating mental health services into midwifery counseling. Given that postpartum mental health in women with a history of preeclampsia has largely been neglected, it is recommended that maternal health policymakers, including those responsible for developing Iran's postpartum care protocols, prioritize timely identification of this high‐risk group and provide appropriate psychological support, including transdiagnostic interventions, to enhance long‐term mental health and quality of life. Furthermore, it is suggested that theoretical training on transdiagnostic interventions and their mechanisms in emotional disorders be incorporated into midwifery counseling education programs. Limitations and Strengths 1.In the present study, coordinating with mothers to participate in educational sessions, given that they were in the postpartum period and were responsible for caring for children under 1 year old, required frequent phone calls, which were time‐consuming. In the present study, coordinating with mothers to participate in educational sessions, given that they were in the postpartum period and were responsible for caring for children under 1 year old, required frequent phone calls, which were time‐consuming. 2.There was a possibility of incomplete completion of the questionnaires, which the researcher tried to monitor by reassuring the samples and emphasizing the confidentiality of the supplementary information. There was a possibility of incomplete completion of the questionnaires, which the researcher tried to monitor by reassuring the samples and emphasizing the confidentiality of the supplementary information. 3.Data were collected based on self‐report instruments, which may be associated with response bias. Data were collected based on self‐report instruments, which may be associated with response bias. 4.The follow‐up period was relatively short; therefore, future studies with longer follow‐up periods (6–12 months) are recommended to examine the sustainability of the intervention effects. The follow‐up period was relatively short; therefore, future studies with longer follow‐up periods (6–12 months) are recommended to examine the sustainability of the intervention effects. 5.The study was conducted in a single‐center setting and in a population of Iranian women, which may limit the generalizability of the findings to other cultural contexts and health systems. The study was conducted in a single‐center setting and in a population of Iranian women, which may limit the generalizability of the findings to other cultural contexts and health systems. The strengths of this study include the existence of a valid treatment protocol and standardized questionnaires. Future Research It is suggested that future studies be conducted with randomized controlled trial designs and blinding of assessors to reduce potential biases and increase the internal validity of the findings. Also, the simultaneous use of objective indicators and biomarkers of stress and emotion regulation, such as cortisol measurements, along with self‐report instruments, can help to more accurately understand the mechanisms of effect of psychological interventions and provide stronger evidence for the effectiveness of these interventions. We suggest that future studies directly compare this intervention with standard treatments using an active control group. Author Contributions Mastaneh Kamravamanesh, Nasrin Jaberghaderi, and Zahra Hatami Asl contributed to the ideation and design of the study. Zahra Hatami Asl contributed to the collection of patient data and implementation of the design steps. Nasrin Jaberghaderi served as the scientific advisor and contributed to the study design, and Mansor Rezaei contributed to the analysis of the results. Zahra Hatami Asl prepared the first draft of the manuscript. Mastaneh Kamravamanesh, Nasrin Jaberghaderi, and Mansor Rezaei critically reviewed the manuscript for important intellectual content. Negin Rezavand contributed to the collection of patient data. All authors have read and approved the final version of the manuscript. Mastaneh Kamravamanesh had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. Ethics Statement This study was approved by the ethics committee of Kermanshah University of Medical Sciences (IR.KUMS.REC.1402.385). All the methods were performed according to the relevant guidelines and regulations. Consent The authors certify that the informed consent forms from all the patients have been obtained. In the forms, the patient(s) has/have given his/their consent for his/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Conflicts of Interest The authors declare no conflicts of interest. Transparency Statement The corresponding author, Mastaneh Kamravamanesh, affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. Acknowledgments We would like to thank the support of the Research Vice‐Chancellor of Kermanshah University of Medical Sciences. Also, we are grateful to all those who helped us conduct this study as best as possible, especially pregnant mothers and hospital personnel affiliated with Kermanshah University of Medical Sciences. This study was derived from a master's thesis in counseling in midwifery and was supported by the Research Vice‐Chancellor of Kermanshah University of Medical Sciences (Grant No. 4020732). The funding body had no role in the design of the study, data collection and analysis, interpretation of the results, or writing and submission of the manuscript. Hatami Asl Z., Jaberghaderi N., Rezaei M., Rezavand N., and Kamravamanesh M., “Investigating the Effect of Transdiagnostic Group Intervention on Depression, Anxiety, and Postpartum Stress in Women With Preeclampsia: A Quasi‐Experimental Study,” Health Science Reports 9 (2026): e72608, 10.1002/hsr2.72608. [Correction added on 26 August 2026, after first online publication: The name of the second author has been corrected.] Data Availability Statement The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. References Associated Data Data Availability Statement The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.